ArticleJournal for immunotherapy of cancer2019

Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer.

Gareth D Healey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.